Global Exosome Diagnostics and Therapeutics Market 2025-2029

Exosome Diagnostics And Therapeutics Market 2025-2029


The exosome diagnostics and therapeutics market is forecasted to grow by USD 1010.2 mn during 2024-2029, accelerating at a CAGR of 26.5% during the forecast period. The report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by raising research on exosome therapeutics, increasing demand for effective drugs for chronic diseases, and growing focus on early detection of cancer.

Technavio's exosome diagnostics and therapeutics market is segmented as below:

By Application
  • Diagnostic
  • Therapeutic
By End-user
  • Research and academic institutes
  • Pharmaceutical and biotechnology companies
  • Commercial
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advanced technology in exosome collection as one of the prime reasons driving the exosome diagnostics and therapeutics market growth during the next few years. Also, potential of exosomes in personalized medicine and rising focus on regenerative medicine will lead to sizable demand in the market.

The report on the exosome diagnostics and therapeutics market covers the following areas:
  • Exosome Diagnostics And Therapeutics Market sizing
  • Exosome Diagnostics And Therapeutics Market forecast
  • Exosome Diagnostics And Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome diagnostics and therapeutics market vendors that include Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., HansaBioMed Life Sciences Ltd., Hologic Inc., JSR Life Sciences LLC, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN N.V., ReNeuron Group plc, Sarepta Therapeutics Inc., System Biosciences LLC, and Thermo Fisher Scientific Inc.. Also, the exosome diagnostics and therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Exosome Diagnostics And Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Exosome Diagnostics And Therapeutics Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Exosome Diagnostics and Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Diagnostic - Market size and forecast 2024-2029
Chart on Diagnostic - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnostic - Market size and forecast 2024-2029 ($ million)
Chart on Diagnostic - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostic - Year-over-year growth 2024-2029 (%)
8.4 Therapeutic - Market size and forecast 2024-2029
Chart on Therapeutic - Market size and forecast 2024-2029 ($ million)
Data Table on Therapeutic - Market size and forecast 2024-2029 ($ million)
Chart on Therapeutic - Year-over-year growth 2024-2029 (%)
Data Table on Therapeutic - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Research and academic institutes - Market size and forecast 2024-2029
Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.5 Commercial - Market size and forecast 2024-2029
Chart on Commercial - Market size and forecast 2024-2029 ($ million)
Data Table on Commercial - Market size and forecast 2024-2029 ($ million)
Chart on Commercial - Year-over-year growth 2024-2029 (%)
Data Table on Commercial - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.12 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.14 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.15 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Aethlon Medical Inc.
Aethlon Medical Inc. - Overview
Aethlon Medical Inc. - Product / Service
Aethlon Medical Inc. - Key offerings
SWOT
14.5 Bio Techne Corp.
Bio Techne Corp. - Overview
Bio Techne Corp. - Business segments
Bio Techne Corp. - Key news
Bio Techne Corp. - Key offerings
Bio Techne Corp. - Segment focus
SWOT
14.6 Capricor Therapeutics Inc.
Capricor Therapeutics Inc. - Overview
Capricor Therapeutics Inc. - Product / Service
Capricor Therapeutics Inc. - Key offerings
SWOT
14.7 Evox Therapeutics Ltd.
Evox Therapeutics Ltd. - Overview
Evox Therapeutics Ltd. - Product / Service
Evox Therapeutics Ltd. - Key offerings
SWOT
14.8 HansaBioMed Life Sciences Ltd.
HansaBioMed Life Sciences Ltd. - Overview
HansaBioMed Life Sciences Ltd. - Product / Service
HansaBioMed Life Sciences Ltd. - Key offerings
SWOT
14.9 Hologic Inc.
Hologic Inc. - Overview
Hologic Inc. - Business segments
Hologic Inc. - Key news
Hologic Inc. - Key offerings
Hologic Inc. - Segment focus
SWOT
14.10 JSR Life Sciences LLC
JSR Life Sciences LLC - Overview
JSR Life Sciences LLC - Product / Service
JSR Life Sciences LLC - Key offerings
SWOT
14.11 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
14.12 Miltenyi Biotec B.V. and Co. KG
Miltenyi Biotec B.V. and Co. KG - Overview
Miltenyi Biotec B.V. and Co. KG - Product / Service
Miltenyi Biotec B.V. and Co. KG - Key news
Miltenyi Biotec B.V. and Co. KG - Key offerings
SWOT
14.13 Nanosomix Inc.
Nanosomix Inc. - Overview
Nanosomix Inc. - Product / Service
Nanosomix Inc. - Key offerings
SWOT
14.14 NX PharmaGen Inc.
NX PharmaGen Inc. - Overview
NX PharmaGen Inc. - Product / Service
NX PharmaGen Inc. - Key offerings
SWOT
14.15 QIAGEN N.V.
QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings
SWOT
14.16 Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc. - Overview
Sarepta Therapeutics Inc. - Product / Service
Sarepta Therapeutics Inc. - Key offerings
SWOT
14.17 System Biosciences LLC
System Biosciences LLC - Overview
System Biosciences LLC - Product / Service
System Biosciences LLC - Key offerings
SWOT
14.18 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Exosome Diagnostics And Therapeutics Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Application - Market share 2024-2029 (%)
Exhibits37: Data Table on Application - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Application
Exhibits39: Data Table on Comparison by Application
Exhibits40: Chart on Diagnostic - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Diagnostic - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Diagnostic - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Diagnostic - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Therapeutic - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Therapeutic - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Therapeutic - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Therapeutic - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Application ($ million)
Exhibits49: Data Table on Market opportunity by Application ($ million)
Exhibits50: Chart on End-user - Market share 2024-2029 (%)
Exhibits51: Data Table on End-user - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by End-user
Exhibits53: Data Table on Comparison by End-user
Exhibits54: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on Commercial - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Commercial - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Commercial - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Commercial - Year-over-year growth 2024-2029 (%)
Exhibits66: Market opportunity by End-user ($ million)
Exhibits67: Data Table on Market opportunity by End-user ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits77: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits129: Market opportunity By Geographical Landscape ($ million)
Exhibits130: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits131: Impact of drivers and challenges in 2024 and 2029
Exhibits132: Overview on criticality of inputs and factors of differentiation
Exhibits133: Overview on factors of disruption
Exhibits134: Impact of key risks on business
Exhibits135: Companies covered
Exhibits136: Company ranking index
Exhibits137: Matrix on companies position and classification
Exhibits138: Aethlon Medical Inc. - Overview
Exhibits139: Aethlon Medical Inc. - Product / Service
Exhibits140: Aethlon Medical Inc. - Key offerings
Exhibits141: SWOT
Exhibits142: Bio Techne Corp. - Overview
Exhibits143: Bio Techne Corp. - Business segments
Exhibits144: Bio Techne Corp. - Key news
Exhibits145: Bio Techne Corp. - Key offerings
Exhibits146: Bio Techne Corp. - Segment focus
Exhibits147: SWOT
Exhibits148: Capricor Therapeutics Inc. - Overview
Exhibits149: Capricor Therapeutics Inc. - Product / Service
Exhibits150: Capricor Therapeutics Inc. - Key offerings
Exhibits151: SWOT
Exhibits152: Evox Therapeutics Ltd. - Overview
Exhibits153: Evox Therapeutics Ltd. - Product / Service
Exhibits154: Evox Therapeutics Ltd. - Key offerings
Exhibits155: SWOT
Exhibits156: HansaBioMed Life Sciences Ltd. - Overview
Exhibits157: HansaBioMed Life Sciences Ltd. - Product / Service
Exhibits158: HansaBioMed Life Sciences Ltd. - Key offerings
Exhibits159: SWOT
Exhibits160: Hologic Inc. - Overview
Exhibits161: Hologic Inc. - Business segments
Exhibits162: Hologic Inc. - Key news
Exhibits163: Hologic Inc. - Key offerings
Exhibits164: Hologic Inc. - Segment focus
Exhibits165: SWOT
Exhibits166: JSR Life Sciences LLC - Overview
Exhibits167: JSR Life Sciences LLC - Product / Service
Exhibits168: JSR Life Sciences LLC - Key offerings
Exhibits169: SWOT
Exhibits170: Merck KGaA - Overview
Exhibits171: Merck KGaA - Business segments
Exhibits172: Merck KGaA - Key news
Exhibits173: Merck KGaA - Key offerings
Exhibits174: Merck KGaA - Segment focus
Exhibits175: SWOT
Exhibits176: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits177: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits178: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibits179: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits180: SWOT
Exhibits181: Nanosomix Inc. - Overview
Exhibits182: Nanosomix Inc. - Product / Service
Exhibits183: Nanosomix Inc. - Key offerings
Exhibits184: SWOT
Exhibits185: NX PharmaGen Inc. - Overview
Exhibits186: NX PharmaGen Inc. - Product / Service
Exhibits187: NX PharmaGen Inc. - Key offerings
Exhibits188: SWOT
Exhibits189: QIAGEN N.V. - Overview
Exhibits190: QIAGEN N.V. - Product / Service
Exhibits191: QIAGEN N.V. - Key news
Exhibits192: QIAGEN N.V. - Key offerings
Exhibits193: SWOT
Exhibits194: Sarepta Therapeutics Inc. - Overview
Exhibits195: Sarepta Therapeutics Inc. - Product / Service
Exhibits196: Sarepta Therapeutics Inc. - Key offerings
Exhibits197: SWOT
Exhibits198: System Biosciences LLC - Overview
Exhibits199: System Biosciences LLC - Product / Service
Exhibits200: System Biosciences LLC - Key offerings
Exhibits201: SWOT
Exhibits202: Thermo Fisher Scientific Inc. - Overview
Exhibits203: Thermo Fisher Scientific Inc. - Business segments
Exhibits204: Thermo Fisher Scientific Inc. - Key news
Exhibits205: Thermo Fisher Scientific Inc. - Key offerings
Exhibits206: Thermo Fisher Scientific Inc. - Segment focus
Exhibits207: SWOT
Exhibits208: Inclusions checklist
Exhibits209: Exclusions checklist
Exhibits210: Currency conversion rates for US$
Exhibits211: Research methodology
Exhibits212: Information sources
Exhibits213: Data validation
Exhibits214: Validation techniques employed for market sizing
Exhibits215: Data synthesis
Exhibits216: 360 degree market analysis
Exhibits217: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings